Abu Dhabi Launches Strategic Life Sciences Corridor to California with Biocom Partnership
In a significant move to bolster the biomedical landscape, Abu Dhabi has formed a strategic partnership with Biocom California, one of the largest associations representing life sciences in the world. This collaboration aims to create a formal bridge between the thriving biotechnology and healthcare ecosystems of both Abu Dhabi and California, thereby enhancing opportunities for innovation, investment, and partnership.
The partnership comes at a time when both regions are focusing on developing advanced healthcare solutions. As reported, the Department of Health of Abu Dhabi (DoH) is set to play a pivotal role as it seeks to facilitate connections among innovators, researchers, investors, and entrepreneurs in both locales. The agreement establishes a pathway for accelerating the development, validation, and scaling of next-generation health solutions.
As part of this initiative, both parties commit to sharing expertise and best practices around the principles of life sciences ecosystem development. This includes insights into sector-specific policies and lessons learned that will strengthen the innovation environment and expedite high-value activities in both areas. The connection between California's prominent life sciences community and Abu Dhabi's 'Health, Endurance, Longevity and Medicine' (HELM) cluster is anticipated to foster numerous opportunities for companies aiming to innovate, test, and scale their ideas.
Notably, through Biocom California, leading biotech, pharmaceutical, and medical device companies in the U.S. will gain access to Abu Dhabi's intelligent life sciences ecosystem and its 'Living Lab' model, where research and practical applications can occur simultaneously in a collaborative setting. Dr. Noura Khamis Al Ghaithi, the Undersecretary at the Department of Health, stated, "The most successful life sciences ecosystems are those that can connect talent, research, investment, and implementation across borders. This partnership with Biocom effectively creates a direct bridge between Abu Dhabi's thriving life sciences ecosystem and one of the world's leading hubs for life science innovation. Innovators, researchers, and investors will benefit from new access to Abu Dhabi’s Living Lab, where scientific discoveries can be rapidly translated into practical applications on a large scale."
Joe Panetta, Honorary Chair of Biocom, expressed his gratitude for this collaboration, recognizing the strategic orientation of Abu Dhabi’s life sciences ecosystem. Panetta commented, "This ambitious partnership will significantly bolster efforts to develop promising new therapies and innovations in life sciences. Biocom is dedicated to forming a network of partnerships within established and emerging life science ecosystems worldwide. Through this agreement, we look forward to collaborating on events, facilitating opportunities for companies to meet in both California and Abu Dhabi, and connecting Abu Dhabi with our other partners."
This strategic collaboration marks an exciting milestone towards enhancing the global life sciences framework, with both Abu Dhabi and California being key players in the expansion of innovative healthcare solutions. The synergy generated through this corridor is expected to propel advancements in biotechnology, pharmaceuticals, and medical technologies, ultimately benefiting the global health community by fostering new therapies and medical solutions that address pressing healthcare challenges.
The partnership comes at a time when both regions are focusing on developing advanced healthcare solutions. As reported, the Department of Health of Abu Dhabi (DoH) is set to play a pivotal role as it seeks to facilitate connections among innovators, researchers, investors, and entrepreneurs in both locales. The agreement establishes a pathway for accelerating the development, validation, and scaling of next-generation health solutions.
As part of this initiative, both parties commit to sharing expertise and best practices around the principles of life sciences ecosystem development. This includes insights into sector-specific policies and lessons learned that will strengthen the innovation environment and expedite high-value activities in both areas. The connection between California's prominent life sciences community and Abu Dhabi's 'Health, Endurance, Longevity and Medicine' (HELM) cluster is anticipated to foster numerous opportunities for companies aiming to innovate, test, and scale their ideas.
Notably, through Biocom California, leading biotech, pharmaceutical, and medical device companies in the U.S. will gain access to Abu Dhabi's intelligent life sciences ecosystem and its 'Living Lab' model, where research and practical applications can occur simultaneously in a collaborative setting. Dr. Noura Khamis Al Ghaithi, the Undersecretary at the Department of Health, stated, "The most successful life sciences ecosystems are those that can connect talent, research, investment, and implementation across borders. This partnership with Biocom effectively creates a direct bridge between Abu Dhabi's thriving life sciences ecosystem and one of the world's leading hubs for life science innovation. Innovators, researchers, and investors will benefit from new access to Abu Dhabi’s Living Lab, where scientific discoveries can be rapidly translated into practical applications on a large scale."
Joe Panetta, Honorary Chair of Biocom, expressed his gratitude for this collaboration, recognizing the strategic orientation of Abu Dhabi’s life sciences ecosystem. Panetta commented, "This ambitious partnership will significantly bolster efforts to develop promising new therapies and innovations in life sciences. Biocom is dedicated to forming a network of partnerships within established and emerging life science ecosystems worldwide. Through this agreement, we look forward to collaborating on events, facilitating opportunities for companies to meet in both California and Abu Dhabi, and connecting Abu Dhabi with our other partners."
This strategic collaboration marks an exciting milestone towards enhancing the global life sciences framework, with both Abu Dhabi and California being key players in the expansion of innovative healthcare solutions. The synergy generated through this corridor is expected to propel advancements in biotechnology, pharmaceuticals, and medical technologies, ultimately benefiting the global health community by fostering new therapies and medical solutions that address pressing healthcare challenges.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.